Synthesis and cytotoxic properties of novel (E)-3-benzylidene-7- methoxychroman-4-one derivatives

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Noushini, Saeedeh ^a   Alipour, Eskandar ^a   Emami, Saeed ^b   Safavi, Maliheh ^c   Ardestani, Sussan Kabudanian ^c   Gohari, Ahmad Reza ^d   Shafiee, Abbas ^e   Foroumadi, Alireza ^d,e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Chalcones; Chroman 4 one; Cytotoxic activity; Synthesis

Indexed keywords

2 (2 CHLORO 6 METHOXYPHENOXY)ACETIC ACID METHYL ESTER ANALOG; 3 BENZYLIDENE 7 METHOXYCHROMAN 4 ONE DERIVATIVE; 3 CHLORO 4,5 DIMETHOXYBENZYLIDENE DERIVATIVE; ALCOHOL; ALDEHYDE; ANTINEOPLASTIC AGENT; BUTYL 2 (4 ((7 METHOXY 4 OXO 2H CHROMEN 3 (4H) YLIDENE)METHYL)PHENOXY)ACETATE; CHLORIDE; CHROMAN DERIVATIVE; CYTOTOXIC AGENT; ETHYL 2 (2 CHLORO 6 ETHOXY 4 ((7 METHOXY 4 OXO 2H CHROMEN 3(4H) YLIDENE)METHYL)PHENOXY)ACETATE; ETHYL 2 (4 ((7 METHOXY 4 OXO 2H CHROMEN 3(4H) YLIDENE)METHYL)PHENOXY)ACETATE; ETOPOSIDE; METHYL 2 (2 CHLORO 6 ETHOXY 4 ((7 METHOXY 4 OXO 2H CHROMEN 3(4H) YLIDENE)METHYL)PHENOXY)ACETATE; METHYL 2 (3 ((7 METHOXY 4 OXO 2H CHROMEN (4H) YLIDENE)METHYL)PHENOXY)ACETATE; METHYL 2 (4 ((7 METHOXY 4 OXO 2H CHROMEN 3 (4H) YLIDENE)METHYL)PHENOXY)ACETATE; METHYL 2 (4 ((7 METHOXY 4 OXO 2H CHROMEN 3(4H) YLIDENE)METHYL)PHENOXY)ACETATE; PROPYL 2 (4 ((7 METHOXY 4 OXO 2H CHROMEN 3(4H) YLIDENE)METHYL)PHENOXY)ACETATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; NEUROBLASTOMA CELL;

EID: 84878545543     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-31     Document Type: Article

References (23)

1. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. Chen YL, Lin SZ, Chang JY, Cheng YL, Tsai NM, Chen SP, Chang WL, Harn HJ, Biochem Pharmacol 2006 72 308 319 10.1016/j.bcp.2006.04.031 16782069 (Pubitemid 43975083)
2. The hallmarks of cancer. Hanahan D, Weinberg RA, Cell 2000 100 57 70 10.1016/S0092-8674(00)81683-9 10647931 (Pubitemid 30046295)
3. Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Ananda Kumar CS, Nanjunda Swamy S, Thimmegowda NR, Benaka Prasad SB, Yip GW, Rangappa KS, Med Chem Res 2007 16 179 187 10.1007/s00044-007-9022-y (Pubitemid 351363183)
4. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents. Reddy MV, Su C-R, Chiou W-F, Liu Y-N, Chen RY-H, Bastow KF, Lee K-H, Wu T-S, Bioorg Med Chem 2008 16 7358 7370 10.1016/j.bmc.2008.06.018 18602831
5. Cytotoxic activity evaluation and QSAR study of chromene-based chalcones. Firoozpour L, Edraki N, Nakhjiri M, Emami S, Safavi M, Ardestani SK, Khoshneviszadeh M, Shafiee A, Foroumadi A, Arch Pharm Res 2012 35 2117 2125 10.1007/s12272-012-1208-2 23263805
6. Chalcone: A versatile molecule. Patil CB, Mahajan SK, Katti SA, J Pharm Sci Res 2009 1 11 22
7. A review of anti-infective and anti-inflammatory chalcones. Nowakowska Z, Eur J Med Chem 2007 42 125 137 10.1016/j.ejmech.2006.09.019 17112640 (Pubitemid 46282233)
8. Chalcones and other compounds from the exudates of and their cancer chemopreventive effects. Akihisa T, Tokuda H, Hasegawa D, Ukiya M, Kimura Y, Enjo F, Suzuki T, Nishino H, J Nat Prod 2006 69 38 42 10.1021/np058080d 16441065 (Pubitemid 43241751)
9. Bioactivities of chalcones. Dimmock JR, Elias DW, Beazely MA, Kandepu NM, Curr Med Chem 1999 6 1125 1149 10519918
10. Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells. Perjési P, Das U, De Clercq E, Balzarini J, Kawase M, Sakagami H, Stables JP, Lorand T, Rozmer Z, Dimmock JR, Eur J Med Chem 2008 43 839 845 10.1016/j.ejmech.2007.06.017 17692998 (Pubitemid 351446154)
11. Identification and characterization of the first small molecule inhibitor of MDMX. Reed D, Shen Y, Shelat AA, Arnold LA, Ferreira AM, Zhu F, J Biol Chem 2010 285 10786 10796 10.1074/jbc.M109.056747 20080970
12. Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study. Nakhjiri M, Safavi M, Alipour E, Emami S, Atash AF, Jafari-Zavareh M, Ardestani SK, Khoshneviszadeh M, Foroumadi A, Shafiee A, Eur J Med Chem 2012 50 113 123 22341788
13. Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes. Mahmoodi M, Aliabadi A, Emami S, Safavi M, Rajabalian S, Mohagheghi MA, Khoshzaban A, Samzadeh-Kermani A, Lamei N, Shafiee A, Foroumadi A, Arch Pharm 2010 7 411 416
14. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities. Fallah-Tafti A, Tiwari R, Shirazi AN, Akbarzadeh T, Mandal D, Shafiee A, Parang K, Foroumadi A, Med Chem 2011 7 466 472 10.2174/157340611796799258 21801146
15. A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study. Bazl R, Ganjali M, Saboury A, Foroumadi A, Nourozi P, Amanlou M, DARU J Pharmaceut Sci 2012 20 64 10.1186/2008-2231-20-64
16. 4-Aryl-4H-naphthopyrans derivatives: One-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities. Rafinejad A, Fallah-Tafti A, Tiwari R, Nasrolahi Shirazi A, Mandal D, Shafiee A, Parang K, Foroumadi A, Akbarzadeh T, DARU J Pharmaceut Sci 2012 20 100 10.1186/2008-2231-20-100
17. 5,6-Dimethoxybenzofuran-3-one derivatives: a novel series of dual Acetylcholinesterase/Butyrylcholinesterase inhibitors bearing benzyl pyridinium moiety. Nadri H, Pirali-Hamedani M, Moradi A, Sakhteman A, Vahidi A, Sheibani V, Asadipour A, Hosseinzadeh N, Abdollahi M, Shafiee A, Foroumadi A, DARU J Pharmaceut Sci 2013 21 15 10.1186/2008-2231-21-15
18. Synthesis and antioxidant properties of substituted 3-benzylidene-7- alkoxychroman-4-ones. Foroumadi A, Samzadeh-kermani A, Emami S, Dehghan G, Sorkhi M, Arabsorkhi F, Heidari MR, Abdollahi M, Shafiee A, Bioorg Med Chem Lett 2007 17 6764 6769 10.1016/j.bmcl.2007.10.034 17967537 (Pubitemid 350061310)
19. Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones. Ayati A, Falahati M, Irannejad H, Emami S, DARU J Pharmaceut Sci 2012 20 46 10.1186/2008-2231-20-46
20. Total syntheses of (+)-chloropuupehenone and (+)-chloropuupehenol and their analogues and evaluation of their bioactivities. Hua DH, Huang X, Chen Y, Battina SK, Tamura M, Noh SK, Koo SI, Namatame I, Tomoda H, Perchellet EM, Perchellet JP, J Org Chem 2004 69 6065 6078 10.1021/jo0491399 15373492 (Pubitemid 39145684)
21. Liquid-phase combinatorial synthesis of 1,4-benzodiazepine-2,5-diones as the candidates of endothelin receptor antagonism. Cheng M-F, Fang J-M, J Comb Chem 2004 6 99 104 10.1021/cc030034d 14714992 (Pubitemid 38142647)
22. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Mosmann T, J Immunol Methods 1983 65 55 63 10.1016/0022-1759(83)90303-4 6606682 (Pubitemid 14203433)
23. Current concerns on the validity of in vitro models that use transformed neoplastic cells in pharmacology and toxicology. Shetab-Boushehri SV, Abdollahi M, Int J Pharmacol 2012 8 594 595 10.3923/ijp.2012.594.595